Perspective Argues Cannabis Should Be Removed From the World Anti-Doping List
A review of the evidence argues cannabis does not enhance athletic performance, its health risks for athletes are overestimated, and its continued prohibition relies primarily on subjective "spirit of sport" criteria rather than science.
Quick Facts
What This Study Found
Cannabis is neither ergogenic (performance-enhancing) nor proven dangerous enough to warrant classification as doping after 20 years of research. CBD is already exempted. The WADA criteria require two of three conditions: performance enhancement, health risk, or violation of the "spirit of sport." The author argues cannabis fails to meet the scientific criteria and is maintained on the list primarily through the subjective moral criterion.
Key Numbers
WADA requires 2 of 3 criteria to be met; CBD already exempted from banned list; 20+ years of research reviewed; cannabis classified as ergolytic (performance-worsening) rather than ergogenic
How They Did This
Narrative perspective reviewing WADA doping criteria and available evidence on cannabis, athletic performance, and health risks in athletes. Examines the three WADA criteria (performance enhancement, health risk, spirit of sport) against published research.
Why This Research Matters
Athletes face career-ending consequences for cannabis use despite lack of evidence it enhances performance. This perspective adds to the growing scientific consensus that the ban is based on outdated moral reasoning rather than evidence of athletic advantage or unique health risk.
The Bigger Picture
The cannabis-as-doping classification affects athletes worldwide and has disproportionately impacted certain populations. As cannabis legalization spreads, the disconnect between civil legality and sporting prohibition grows harder to justify on scientific grounds.
What This Study Doesn't Tell Us
Perspective piece rather than systematic review, which may selectively present evidence. The "spirit of sport" criterion is inherently subjective and was designed to capture behaviors beyond pure performance enhancement. Athletes in different sports may face different risk profiles.
Questions This Raises
- ?Will WADA eventually remove cannabis from its prohibited list?
- ?Would removal lead to increased cannabis use among athletes?
- ?How should athletic organizations handle cannabis in jurisdictions where it is legal?
Trust & Context
- Key Stat:
- Cannabis is ergolytic, not ergogenic
- Evidence Grade:
- Evidence-based perspective from published literature, but not a systematic review and presents a specific advocacy position
- Study Age:
- 2023 study
- Original Title:
- Cannabis Is Not Doping.
- Published In:
- Cannabis and cannabinoid research, 8(6), 949-954 (2023)
- Authors:
- Aguiar, Aderbal Silva
- Database ID:
- RTHC-04350
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis improve athletic performance?
No. According to this review and the broader literature, cannabis is ergolytic, meaning it worsens rather than improves athletic performance. It impairs coordination, reaction time, and exercise capacity.
Why is cannabis still banned in sports?
The author argues it remains banned primarily because of the subjective "spirit of sport" criterion, which functions more as moral policing than evidence-based regulation. The scientific criteria (performance enhancement and health risk) are not well supported.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-04350APA
Aguiar, Aderbal Silva. (2023). Cannabis Is Not Doping.. Cannabis and cannabinoid research, 8(6), 949-954. https://doi.org/10.1089/can.2023.0012
MLA
Aguiar, Aderbal Silva. "Cannabis Is Not Doping.." Cannabis and cannabinoid research, 2023. https://doi.org/10.1089/can.2023.0012
RethinkTHC
RethinkTHC Research Database. "Cannabis Is Not Doping." RTHC-04350. Retrieved from https://rethinkthc.com/research/aguiar-2023-cannabis-is-not-doping
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.